97360 ⎘
Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
Sub-classes:PHYSIOLOGICALLY-ACTIVE PEPTIDE DERIVATIVE FOR TREATMENT OF EYE DISEASES, PHARMACEUTICAL COMPOSITION, NASAL/NASAL DROP PREPARATION, AND USE OF PHYSIOLOGICALLY-ACTIVE PEPTIDE DERIVATIVE
#2PFCSP-BASED IMMUNOGENS AND RELATED COMPOSITION AND METHODS
#3AFFINITY CHROMATOGRAPHY LIGANDS FOR ANTIBODY GLYCOVARIANT SEPARATION
#4INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE
#5GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND APPLICATIONS THEREOF
#6NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES
#7Antibodies with Engineered O-Glycosylation Sequons for Site-Specific Conjugation
#8VARIANTS OF ALPHA-1-ANTITRYPSIN
#9FUSION PROTEINS COMPRISING 071 CORE PEPTIDE AND USE THEREOF
#10METHODS FOR SITE SPECIFIC CONJUGATION OF PROTEINS CONTAINING GLYCOSYLATED Fc DOMAINS
#11PLASMID PLATFORM FOR STABLE EXPRESSION AND DELIVERY OF BIOMOLECULES
#12TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES
#13Glycoengineered Foldon Domains and Related Compositions and Methods
#14GLYCOSYLATED COMP PILIN VARIANTS, METHODS OF MAKING AND USES THEREOF
#15SARS-COV-2 RBD CONSTRUCTS
#16MODIFIED POLYPEPTIDES WITH IMPROVED PROPERTIES
#17Vaccines against HPV and HPV-related diseases
#18Immunogenic Coronavirus Fusion Proteins and Related Methods
#19GLYCOSYLATED IL-2 PROTEINS AND USES THEREOF
#20GLYCOSYLATION-MODIFIED ERYTHOPOIETIN AND USE THEREOF
#21METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES
#22BINDING MOLECULES WITH MODIFIED J-CHAIN
#23MODIFIED CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#24SYNTHETIC ALPHA-SECRETASE AND USE THEREOF
#25Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
#26Recombinant vector for expressing target protein in plant cell
#27Methods of use of soluble CD24 for treating lupus nephritis
#28CELL PENETRATING PEPTIDES
#29ACE2-Fc FUSION PROTEINS FOR SARS-COV-2 MITIGATION
#30Methods for site specific conjugation of proteins containing glycosylated Fc domains
#31GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE
#32Glycosylated ComP pilin variants, methods of making and uses thereof
#33Fusion proteins comprising an anti-CD40 antibody and cancer antigens
#34Fusion protein with half-life extending polypeptide
#35LICHENASE-COVID-19 BASED VACCINE
#36ENGINEERED DNASE ENZYMES AND USE IN THERAPY
#37RECOMBINANT GRP94 CHAPERONES AND METHODS OF USING THE SAME TO MODULATE GLYCOSYLATION IN FUSION PROTEINS
#38Materials and methods for inhibiting flavivirus infection
#39Vaccines against HPV and HPV-related diseases
#40Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates
#41DNase therapy for intravascular accumulation of extracellular DNA
#42LONG-ACTING IGF-1 OR IGF-1 VARIANTS AND METHODS OF PRODUCING SAME
#43DNase therapy for intravascular accumulation of extracellular DNA
#44Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#45Recombinant vector for expressing target protein in plant cell
#46Engineered DNase enzymes and use in therapy
#47Binding molecules with modified J-chain
#48Compositions and methods of use for treating metabolic disorders
#49Multivalent glycopeptides that tightly bind to target proteins
#50CELL PENETRATING PEPTIDES
#51Directed evolution of multivalent glycopeptides that tightly bind to target proteins
#52Ligands Modified by Circular Permutation as Agonists and Antagonists
#53Engineered DNase enzymes and use in therapy
#54METHODS AND COMPOSITIONS FOR TREATING HPA HYPERACTIVITY
#55Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
#56Vaccines against HPV and HPV-related diseases
#57Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use
#58Modified chimeric antigen receptors and methods of use
#59Recombinant human C1 esterase inhibitor and uses thereof
#60Binding molecules with modified J-chain
#61LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME
#62Compositions and Methods of Use for Treating Metabolic Disorders
#63Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides
#64Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof
#65UTI fusion proteins
#66Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates
#67Fusion proteins comprising an anti-CD40 antibody and cancer antigens
#68GLYCOSYLATION MUTANTS FOR PRODUCING GALACTOSE-FREE AND FUCOSE-FREE POLYPEPTIDES
#69Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#70Modified glycoproteins
#71Genetically encoded histone reporter allele constructs
#72Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#73Combinatorial platform for the display of surface adjuvants and antigens
#74Ligands modified by circular permutation as agonists and antagonists
#75UTI fusion proteins
#76Fusion tags for protein expression
#77Vaccines against HPV and HPV-related diseases
#78Directed evolution of multivalent glycopeptides that tightly bind to target proteins
#79Multivalent glycopeptides that tightly bind to target proteins
#80Long-acting coagulation factors and methods of producing same
#81Fusion polypeptides comprising mucin-domain polypeptide linkers
#82Influenza virus vaccines and uses thereof
#83Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
#84Glycosylated VEGF decoy receptor fusion protein
#85Compositions and methods of use for treating metabolic disorders
#86Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein
#87CTP-based insulin analogs for treatment of diabetes
#88METHODS OF TREATMENT USING FUSION PROTEINS
#89Long-acting polypeptides and methods of producing same
#90COMPOSITIONS AND METHODS FOR INCREASING SERUM HALF-LIFE
#91Long-acting polypeptides and methods of producing same
#92Ligands modified by circular permutation as agonists and antagonists
#93Ligands modified by circular permutation as agonists and antagonists
#94Compositions and methods for increasing serum half-life
#95Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions
#96Long-acting polypeptides and methods of producing same
#97MODIFIED LINKERS
#98N-GLYCOSYLATED HUMAN GROWTH HORMONE WITH PROLONGED CIRCULATORY HALF-LIFE
#99Fusion proteins comprising antibody and HPV E6 and E7 antigens
#100Anti-CD40 targeted fusion proteins
#101Fusion protein with HIV antigen
#102Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#103Long-acting polypeptides and methods of producing same
#104COMPOSITIONS AND METHODS FOR INHIBITING SHIGA TOXIN AND SHIGA-LIKE TOXIN
#105Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF
#106Expression and secretion of icIL-1 receptor antagonist type II
#107Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol
#108Compositions and methods for monitoring enzyme activity